Allspring Global Investments’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$252K Sell
10,844
-644
-6% -$15K ﹤0.01% 1509
2025
Q1
$277K Buy
+11,488
New +$277K ﹤0.01% 1600
2024
Q4
Sell
-100,181
Closed -$1.51M 2228
2024
Q3
$1.51M Buy
100,181
+93,497
+1,399% +$1.41M ﹤0.01% 1235
2024
Q2
$191K Sell
6,684
-3,504
-34% -$100K ﹤0.01% 1717
2024
Q1
$298K Buy
10,188
+5,433
+114% +$159K ﹤0.01% 1631
2023
Q4
$160K Buy
4,755
+274
+6% +$9.25K ﹤0.01% 1724
2023
Q3
$137K Buy
4,481
+1,736
+63% +$53.3K ﹤0.01% 1880
2023
Q2
$110K Sell
2,745
-77,244
-97% -$3.1M ﹤0.01% 2012
2023
Q1
$3.26M Buy
79,989
+39,973
+100% +$1.63M 0.01% 1108
2022
Q4
$1.55M Sell
40,016
-186,748
-82% -$7.21M ﹤0.01% 1312
2022
Q3
$12.1M Sell
226,764
-11,863
-5% -$631K 0.02% 708
2022
Q2
$13.9M Buy
238,627
+148,043
+163% +$8.63M 0.02% 688
2022
Q1
$6.91M Sell
90,584
-4,407
-5% -$336K 0.01% 1018
2021
Q4
$5.71M Buy
+94,991
New +$5.71M 0.01% 1129